Bincy Abraham

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Prometheus
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
    Relationship end date:
    12/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Johnson and JOhnson
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Celltrion
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lilly
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ironwood
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    IBD
    Date added:
    05/08/2025
    Date updated:
    05/08/2025

Pages

Return to 108 Digestive and Liver Core Curriculum: "Point of Care IUS in the Management of IBD" (052125)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.